Search results

  1. V.R.T.

    Peripheral neurons, CRH, and sickness behavior

    Could you explain this part for the more brain fogged among us (i.e. me!) This discussion is really interesting but I dont quite follow this bit.
  2. V.R.T.

    Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis, 2026, Shammas et al

    I haven't heard of them being tried - i dont know much about them, could you explain their relevance to this paper?
  3. V.R.T.

    Narratives of recovery from persistent fatigue: a stepwise learning process 2026 Linnros et al

    No because you see, our magic brains made us sick because we were doing life all wrong and so all these people needed to be paid the big bucks to teach us to go for a walk in nature and have a chat with our families and maybe do some sit ups. We could never have thought of this on our own. So...
  4. V.R.T.

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study, 2026, Koller+

    Hopefully it will cause a great deal of harm to the authors reputations when the science comes through for us. This is all going to look as utterly indefensible as it really is. Unfortunately in the meantime it will get pwME and LC sectioned and forced into harmful 'therapies'
  5. V.R.T.

    A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID, 2026, Kumar et al

    That's disappointing but it sort of makes sense, thanks.
  6. V.R.T.

    A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID, 2026, Kumar et al

    Perhaps some of the bright minds on here might be able to make something of it!
  7. V.R.T.

    ATP bioenergetics and fatigue in young adults with and without major depression, 2026, Cullen

    Or they never find it, because antidepressants dont work for anywhere close to everyone and therapy isn't enough.
  8. V.R.T.

    Narratives of recovery from persistent fatigue: a stepwise learning process 2026 Linnros et al

    This is definitely part of it - to shut people out of medicine, but it also provides a neat story for doctors, insurers, NHS providers etc about why they are shunning the nasty heartsink patients. Its not that we dont understand whats wrong with them, its that they're bad and dont want to get...
  9. V.R.T.

    Narratives of recovery from persistent fatigue: a stepwise learning process 2026 Linnros et al

    I actually think that drawing comparisons between Eysenck and the work of the MECFS psychobehaviouralists might be a good way of highlighting how empty and fraudulent it is.
  10. V.R.T.

    Narratives of recovery from persistent fatigue: a stepwise learning process 2026 Linnros et al

    There was a researcher at Kings College London who made his name on just this sort of thing - Hans Eyesik, something like that. Was later found to have committed fraud in his papers. All sort of 'a certain type of person gets/dies from cancer' - negative people, anxious people etc.
  11. V.R.T.

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study, 2026, Koller+

    I have no idea but it would be incredibly funny if it wasn't so deeply destructive and frightening. These people think they are doing science. They think this parade of woo nonsense and reheated Freudianism is good science. And apparently so do the people that fund them.
  12. V.R.T.

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study, 2026, Koller+

    This paper is going to cause harm.
  13. V.R.T.

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    I've seen reports of people made a lot worse from Pemgarda too. I think at a certain point these researchers need to see the writing on the wall and pivot. But not towards the placebo effect :banghead:
  14. V.R.T.

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    Yeah you feel like quoting mean girls at them 'Stop trying to make viral persistance happen'
  15. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    It does seem ambitious but given how quickly fluge and mella got going on dara p2 perhaps not impossible.
  16. V.R.T.

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    Yeah this is disappointing and bizarre
  17. V.R.T.

    Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of [LC]: RECOVER-VITAL, 2026, Zimmerman+

    Because they haven't wasted enough time looking for what almost certainly isn't there.
  18. V.R.T.

    Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19, 2026, Ray et al

    One of these days, one of these studies will live up to the hype. Well, I guess it probably won't be hyped up by The Twitterati feat ChatGPT, but it will actually show something major.
  19. V.R.T.

    Prevalence of Multiple Chemical Sensitivity in Canada Between 2000 and 2020, 2026, Robins et al

    Heres some talk about OLFM4 in this context
  20. V.R.T.

    Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19, 2026, Ray et al

    Okay so what do we think, does this live up to the hype of these twitter posts?
Back
Top Bottom